The herb
Salviamiltiorrhiza Bunge (Lamiaceae) is widely recognized in traditional Chinese medicine for its exceptional efficacy in ameliorating microcirculatory disturbances (
1). Tanshinones, a group of terpenoids comprising tanshinone I, dihydrotanshinone I, tanshinone IIA, and cryptotanshinone, represent the primary bioactive constituents found in
S. miltiorrhiza. Tanshinone IIA is commercially synthesized from the dried roots of
S. miltiorrhiza, a process commonly employed in the industrial production of this compound. In recent years, various biological benefits of tanshinone IIA have been discovered, including the treatment of myocardial infarction, coronary heart disease, and angina (
2-
4). It also demonstrates substantial anti-tumor, antiviral, and neuroinflammatory alleviating effects (
5-
8). Due to excessive collection of wild resources, the natural supply of this medicinal plant is currently limited. Various techniques have been employed to enhance tanshinone production from
S. miltiorrhiza roots, including tissue cultures, microwave-assisted extraction (MAE) (
9), beta-aminobutyric acid induction (
10), and biotic and abiotic elicitors (
11); however, the issue of resource scarcity for
S. miltiorrhiza remains unresolved.
The potential of endophytes as reservoirs of natural products for industrial, agricultural, and pharmaceutical applications has been widely recognized in recent decades, particularly regarding the secondary metabolites produced by fungal endophytes inhabiting medicinal plants (
12). However, the current production of highly potent secondary metabolites reported in various endophytes, such as
Gentiana macrophylla (
13),
Icacinaceae (
14), and
Forsythia suspensa (
15), remains limited. The endophytic fungus
Emericella foeniculicola TR21 (
Aspergillus) was isolated from the roots of
S. miltiorrhiza to explore an alternative natural source of tanshinone IIA production. However, the yield of tanshinone IIA (YT) also remained relatively low (
16).
The protoplast mutation is a highly effective approach for addressing this issue within different mutation breeding techniques, resulting in the acquisition of improved mutants through mutagenic or chemostat-mediated adaptation. In this process, the cytomembrane of isolated protoplasts is fully exposed, rendering them highly susceptible to the external environment. Previous studies have reported that
Cordyceps militaris SU5-08 was obtained by subjecting the initial strain (
C. militaris SU5) to ultraviolet mutagenesis of protoplasts, resulting in an extraction rate of exopolysaccharide (EPS) at 1919.16 ± 165.27 mg/L, which surpassed that of
C. militaris SU5 (
17). The marine-derived fungus
Aspergillus sp. NRCF5 was utilized to induce genetic variability through the application of various combinations and doses of mutagens. Five mutants exhibiting high xylanase activity and a tolerance of 0.25% (w/v) to the antimetabolite 2-deoxyglucose (2DG) were isolated from populations generated by combining UV and NTG mutations (
18). The protoplast mutation method can thus be employed for TR21 to obtain mutant strains with enhanced tanshinone IIA yield, establishing a novel pathway for the production of tanshinone IIA.